1. Home
  2. Author
  3. Bernard SG

Bernard SG

References (2)

Title : Phase 1 and pre-clinical profiling of ESM-HDAC391, a myeloid-targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia - Furze_2022_Br.J.Clin.Pharmacol__
Author(s) : Furze RC , Molnar J , Parr NJ , Ahmad F , Henry Y , Howe D , Singh R , Toal M , Bassil AK , Bernard SG , Davis RP , Gibson A , Maller NC , Sharp C , Tough DF , Prinjha RK , Lewis HD
Ref : British Journal of Clinical Pharmacology , : , 2022
Abstract :
PubMedSearch : Furze_2022_Br.J.Clin.Pharmacol__
PubMedID: 35655123

Title : Targeting Histone Deacetylases in Myeloid Cells Inhibits Their Maturation and Inflammatory Function With Limited Effects on Atherosclerosis - Luque-Martin_2019_Front.Pharmacol_10_1242
Author(s) : Luque-Martin R , Van den Bossche J , Furze RC , Neele AE , van der Velden S , Gijbels MJJ , van Roomen C , Bernard SG , de Jonge WJ , Rioja I , Prinjha RK , Lewis HD , Mander PK , de Winther MPJ
Ref : Front Pharmacol , 10 :1242 , 2019
Abstract :
PubMedSearch : Luque-Martin_2019_Front.Pharmacol_10_1242
PubMedID: 31736752